Impetigo contagiosa III. Comparative efficacy of oral erythromycin and topical mupirocin

Clicks: 411
ID: 273723
1989
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #1 of 6 articles by views in pediatric dermatology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Ninety-seven patients with impetigo were prospectively enrolled in a study to determine the comparative efficacy of systemic and topical antibiotic therapy. After obtaining a bacterial culture from a representative lesion, the children were randomized to receive seven days of either oral erythromyci …
Reference Key
ll1989pediatricimpetigo Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Barton LL;Friedman AD;Sharkey AM;Schneller DJ;Swierkosz EM;;
Journal pediatric dermatology
Year 1989
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/2501775
Keywords
Administration National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't female male adolescent Child Infant Comparative Study Prospective Studies preschool Clinical Trial Randomized Controlled Trial Random Allocation drug resistance staphylococcus aureus / isolation & purification microbial streptococcus / isolation & purification anti-bacterial agents / therapeutic use* impetigo / drug therapy* oral erythromycin / administration & dosage topical erythromycin / adverse effects erythromycin / therapeutic use* fatty acids / metabolism erythromycin / metabolism pmid:2501775 doi:10.1111/j.1525-1470.1989.tb01012.x l l barton a d friedman e m swierkosz fatty acids / administration & dosage fatty acids / adverse effects fatty acids / therapeutic use impetigo / pathology mupirocin

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.